Shire gets favorable ruling against Allergan in Lialda patent case
March 28 (Reuters) - A U.S. district court on Monday ruled in favor of Shire Plc, preventing Allergan Plc from selling generic versions of Lialda, the ulcerative colitis drug, in the United States until 2020.
No comments:
Post a Comment